跳至主要内容
临床试验/JPRN-UMIN000023719
JPRN-UMIN000023719已完成未知

Effect of adalimumab dose escalation in patients with Crohn's disease - Effect of adalimumab dose escalation in patients with Crohn's disease

Shiga University of Medical Science0 个研究点目标入组 0 人开始时间: 2016年8月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
15years-old 至 99years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients without intestinal mucosal lesion 2. Patients with active tuberculosis 3. Patients with demyelinating disease 4. Patients with chronic heart failure 5. Serum creatinine more than 2 mg/dl 6. Total bilirubin more than 2 mg/dl 7. AST or ALT more than 50 IU/l 8. Patients under pregnancy or breast-feeding 9. Patients who wishes to become pregnant 10. Less than 15 years old 11. Patients who has neoplasm 12. Patients who have psychoneurotic disorder 13. Patients who do not agree to join this study 14. When the doctor in charge feel that the patients are not suitable for this study

研究者

相似试验